Biomarkers in the pharmaceutical industry.

Laterza, Omar F; Plump, Andrew; Ming, Jeffrey E; Richards, Susan; Burczynski, Michael E Ransom; Wagner, John A; Patterson, Scott D

Laterza, Omar F; Plump, Andrew; Ming, Jeffrey E; Richards, Susan; Burczynski, Michael E Ransom; Wagner, John A; Patterson, Scott D.

Afiliação

Laterza OF; Director, Immunochemistry and Mass Spectrometry, Molecular Biomarkers and Diagnostics, Merck Research Laboratories, Rahway, NJ; omar.laterza@merck.com.
Plump A; Senior Vice President, Deputy to the President, Research & Translational Medicine, Sanofi, Paris, France;
Ming JE; Senior Director, Clinical & Exploratory Pharmacology, Sanofi, Bridgewater, NJ;
Richards S; Group Vice President, Clinical Laboratory Sciences, Disposition, Safety and Animal Research, Sanofi, Framingham, MA;
Burczynski ME; Executive Director, Biomarker Technologies, Bristol-Myers Squibb Co., Lawrenceville, NJ;
Wagner JA; Vice President and Head of Global Experimental Medicine, Takeda Pharmaceuticals, Cambridge, MA;
Patterson SD; Executive Director, Medical Sciences, Amgen, Thousand Oaks, CA.

Clin Chem ; 61(4): 579-83, 2015 Apr.

Article em En | MEDLINE | ID: mdl-25376580

Assuntos

Biomarcadores/análise; Preparações Farmacêuticas/análise; Humanos; Controle de Qualidade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Biomarcadores Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google